TSHA Taysha Gene Therapies, Inc.
Healthcare$5.49-0.90%ClosedMarket Cap: $1.37B
As of 2026-05-25
Insider Statistics (Q1 2026)
Acquisitions
8
Dispositions
10
Buy/Sell Ratio
0.80
Net Shares
+2,348,377
Shares Acquired
3,147,000
Shares Disposed
798,623
Total Bought ($)
$0.00
Total Sold ($)
$8.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Apr 13 | Nagendran Sukumar | director, officer: President and Head of R&D | Sell | 200,000 | $4.46 | 1,136,410 |
| Mon Apr 13 | Nagendran Sukumar | director, officer: President and Head of R&D | Sell | 19,021 | $1.71 | 1,336,410 |
| Fri Feb 06 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | Sell | 1,655 | $4.52 | 1,442,131 |
| Tue Jan 27 | Nolan Sean P. | director, officer: Chief Executive Officer | Sell | 136,789 | $4.75 | 2,949,569 |
| Tue Jan 27 | Nolan Sean P. | director, officer: Chief Executive Officer | Sell | 41,312 | $4.61 | 2,908,257 |
| Tue Jan 27 | Nagendran Sukumar | director, officer: President and Head of R&D | Sell | 89,132 | $4.75 | 1,344,307 |
| Tue Jan 27 | Nagendran Sukumar | director, officer: President and Head of R&D | Sell | 26,918 | $4.61 | 1,317,389 |
| Tue Jan 27 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | Sell | 78,968 | $4.75 | 1,467,635 |
| Tue Jan 27 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | Sell | 23,849 | $4.61 | 1,443,786 |
| Wed Jan 14 | Nolan Sean P. | director, officer: Chief Executive Officer | Sell | 1,008,000 | $0.00 | 3,086,358 |
| Wed Jan 14 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | Sell | 359,000 | $0.00 | 1,546,603 |
| Wed Jan 14 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | Sell | 231,000 | $4.86 | 231,000 |